IMPPC Fundación Institut de Medicina Predictiva i Personalitzada del Càncer

• > Welcome from the Director
• > Biosketch of the director

Welcome from the Director

Thank you for taking the time to visit our webpage. It is for me a great honor to be the director of the Institute of Predictive and Personalized Medicine of Cancer. After many years researching the mechanisms behind hereditary cancers, in particular hereditary nonpolyposis colorectal cancer (HNPCC) I can confirm that we are now very much closer than ever before to a new paradigm of medicine, in which the genetic profile of healthy individuals will be stored with their medical history and used to predict and prevent disease before it develops. Indeed, this is already possible for some hereditary cancers and the work of the IMPPC aims to extend this to other forms of the disease as well as identifying diagnostic and therapeutic tools.
In this welcome I would like to express my gratitude to the Generalitat of Catalonia, especially to the Department of Innovation, Universities and Enterprise and the Department of Health for confiding in me to set up and direct the IMPPC.

We are very grateful for the work of our trustees, who have supported our efforts as we have set up the institute. Our trustees represent: the Consejo Superior de Investigaciones Científicas (CSIC), the Universitat Autònoma de Barcelona (UAB) (Autonomous University of Barcelona), the City Council of Badalona, the Catalan Institute of Health (ICS), The Germans Trias i Pujol University Hospital (HUGTiP) and the Institute for Health Science Research Germans Trias i Pujol (FIICSGTiP.

I would also like to thank all the members of the scientific community who have expressed an interest in the IMPPC and especially to those who are joining us this year. Our scientific reputation will depend on the work of the groups these investigators are now setting up and we are proud to have them with us.
It is an exciting time to be involved in biomedical research and being invited to direct the new Institute of Predictive and Personalized Medicine of Cancer, a new center in the CERCA Program of the Generalitat, is a source of great personal satisfaction to me. The IMPPC will contribute vital science required for a change in the way we treat disease but it will also be part of a brand new network which is putting Barcelona on the world map for biomedicine

 

Manuel Perucho
Director
ICREA Research Professor at the IMPPC